Article in Pharmaceutics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
15 authors.
Tijana StankovićDepartment of Pharmaceutical Technology and Cosmetology, Faculty of Pharmacy, University of Belgrade, 11211 Belgrade, Serbia.
Tanja IlićDepartment of Pharmaceutical Technology and Cosmetology, Faculty of Pharmacy, University of Belgrade, 11211 Belgrade, Serbia.
Branka Divović MatovićDepartment of Pharmacology, Faculty of Pharmacy, University of Belgrade, 11211 Belgrade, Serbia.
Milos PetkovicDepartment of Organic Chemistry, Faculty of Pharmacy, University of Belgrade, 11211 Belgrade, Serbia.ORCID 0000-0001-9637-1380
Vladimir DobričićDepartment of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Belgrade, 11211 Belgrade, Serbia.ORCID 0000-0002-5086-9017
Ivan JančićDepartment of Microbiology and Immunology, Faculty of Pharmacy, University of Belgrade, 11211 Belgrade, Serbia.
Biljana BufanDepartment of Microbiology and Immunology, Faculty of Pharmacy, University of Belgrade, 11211 Belgrade, Serbia.
Kristina JezdićDepartment of Pharmacology, Faculty of Pharmacy, University of Belgrade, 11211 Belgrade, Serbia.ORCID 0009-0000-2208-2252
Jelena ĐokovićDepartment of Pharmaceutical Technology and Cosmetology, Faculty of Pharmacy, University of Belgrade, 11211 Belgrade, Serbia.ORCID 0000-0003-0936-4276
Ivana PantelićDepartment of Pharmaceutical Technology and Cosmetology, Faculty of Pharmacy, University of Belgrade, 11211 Belgrade, Serbia.ORCID 0000-0001-6164-4457
Danijela RandjelovićInstitute of Chemistry, Technology and Metallurgy, National Institute of the Republic of Serbia, University of Belgrade, 11000 Belgrade, Serbia.ORCID 0000-0003-0780-5058
Dishary SharminDepartment of Chemistry and Biochemistry, Milwaukee Institute for Drug Discovery, University of Wisconsin-Milwaukee, Milwaukee, WI 53211, USA.
James M CookDepartment of Chemistry and Biochemistry, Milwaukee Institute for Drug Discovery, University of Wisconsin-Milwaukee, Milwaukee, WI 53211, USA.ORCID 0000-0001-5512-3022
Miroslav M SavićDepartment of Pharmacology, Faculty of Pharmacy, University of Belgrade, 11211 Belgrade, Serbia.
Snežana SavićDepartment of Pharmaceutical Technology and Cosmetology, Faculty of Pharmacy, University of Belgrade, 11211 Belgrade, Serbia.ORCID 0000-0002-6236-9730
Funding
Tolerance and Physical Dependence after Chronic Benzodiazepine TreatmentR01DA043204 · NIDA · UNIVERSITY OF MISSISSIPPI MED CTR · PI JAMES K ROWLETT · 2017 to 2026
$4.3M
Benzodiazepine Choice and Polydrug UseR01DA054177 · NIDA · UNIVERSITY OF MISSISSIPPI MED CTR · PI Sally L Huskinson · 2022 to 2026
$2.5M
GABA-A receptor subtype mechanisms and the abuse-related effects of alcoholR01AA029023 · NIAAA · UNIVERSITY OF MISSISSIPPI MED CTR · PI PLATT, DONNA M · 2020 to 2024
$2.4M
Ministry of Education, Science and Technological Development, Republic of Serbia through a Grant Agreement with the University of Belgrade-Faculty of Pharmacy 451-03-65/2024-03/200161 and 451-03-66/2024-03/200161.NIAAA NIH HHS R01 AA029023NIDA NIH HHS R01 DA043204NIDA NIH HHS R01 DA054177NIH/NIDA 2R01 DA043204-06A1Science Fund of the Republic of Serbia 7749108
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Intravenous Nanoemulsions Loaded with Phospholipid Complex of a Novel Pyrazoloquinolinone Ligand for Enhanced Brain Delivery. · full record | OpenQuestion